Home

Lysozyme encapsulated gold nanoclusters – new therapeutic agent for Alzheimer’s Disease (360G-RSMCT-0064K00000AoQ5E)

Funding Organization
£30,000
Recipient Organization

A total of £30,000 is requested to help fund the proposed study to determine the effect of lysozyme encapsulated gold nanoclusters on modulating the pathophysiology of Alzheimer's Disease, which may lead to the development of novel therapeutic strategies for patients.

Where is this data from?

This data was originally published by R S Macdonald Charitable Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 30000
Award Date 2022-11-24T00:00:00+00:00
Data Source https://www.rsmacdonald.com/reports
Last Modified 2023-06-08T00:00:00+00:00
Recipient Org: Charity Number SC015263
Recipient Org: City Glasgow
Recipient Org: Postal Code G1 1XQ
Recipient Org: Web Address https://www.strath.ac.uk/

Allow analytics cookies?
More Information & Privacy Policy

Yes No Disable Analytics